Scholarlink

<p>Fragile X syndrome (FXS), the most common form of inherited intellectual disability, results from a loss of fragile X mental retardation protein (FMRP), an RNA-binding protein whose deficiency impacts many targeted mRNA and brain functions. However, how these FMRP targets contribute to the pathogenesis of FXS is not fully understood, and effective treatment is lacking. Here, we identify signal transducer and activator of transcription 3 (STAT3) as a target of FMRP in adult hippocampal neural stem cells (NSCs). FMRP regulates <i>Stat3</i> mRNA stability and protein translation, and loss of FMRP results in elevated <i>Stat3</i> mRNA and protein, leading to aberrant neurogenesis and impaired dendritic maturation in adult NSCs and developing neurons. Activation of <i>Stat3</i>&#xa0;in adult mouse hippocampal NSCs impairs cognitive flexibility. We show that STAT3 phosphorylation specifically binds to MYC, which is essential for adult hippocampal neurogenesis. Both genetic reduction of STAT3 and pharmacological treatment with artesunate, the first-line drug for treating malaria worldwide, rescue neurogenic and cognitive deficits in FMRP-deficient mice. Our work reveals a potential regulatory role for FMRP and STAT3-MYC signaling pathway in adult neurogenesis and cognitive flexibility, and provides a potential novel therapeutic strategy for treating adult FXS patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

FMRP regulation of STAT3-MYC signaling is critical for adult hippocampal neurogenesis and cognitive flexibility

  • 期刊论文

  • 发表日期：

    2025年7月19日

查看全文
  • Yue Li,
  • Wenxin Ma,
  • Ruishuang Ma,
  • Shuang Wang,
  • Xu Liu,
  • Xiaomeng Guo,
  • Wenhua Li,
  • Xiaopeng Chen,
  • Yuan-Lu Cui,
  • He Song

摘要

Fragile X syndrome (FXS), the most common form of inherited intellectual disability, results from a loss of fragile X mental retardation protein (FMRP), an RNA-binding protein whose deficiency impacts many targeted mRNA and brain functions. However, how these FMRP targets contribute to the pathogenesis of FXS is not fully understood, and effective treatment is lacking. Here, we identify signal transducer and activator of transcription 3 (STAT3) as a target of FMRP in adult hippocampal neural stem cells (NSCs). FMRP regulates Stat3 mRNA stability and protein translation, and loss of FMRP results in elevated Stat3 mRNA and protein, leading to aberrant neurogenesis and impaired dendritic maturation in adult NSCs and developing neurons. Activation of Stat3 in adult mouse hippocampal NSCs impairs cognitive flexibility. We show that STAT3 phosphorylation specifically binds to MYC, which is essential for adult hippocampal neurogenesis. Both genetic reduction of STAT3 and pharmacological treatment with artesunate, the first-line drug for treating malaria worldwide, rescue neurogenic and cognitive deficits in FMRP-deficient mice. Our work reveals a potential regulatory role for FMRP and STAT3-MYC signaling pathway in adult neurogenesis and cognitive flexibility, and provides a potential novel therapeutic strategy for treating adult FXS patients.